Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WW domain-binding protein 4 (WBP4), also known as formin-binding protein 21 (FBP21), is a spliceosomal protein that plays a role in the assembly and function of the spliceosome, specifically involved in pre-mRNA splicing. The WW domain is a small, globular protein domain that binds to proline-rich motifs and is important for mediating protein-protein interactions within the spliceosomal complex. WBP4 may participate in bridging U1 and U2 small nuclear ribonucleoproteins (snRNPs) during formation of the A complex of the spliceosome. Mutations in the WBP4 gene have been associated with neurodevelopmental disorders and certain forms of cerebral amyloid angiopathy[1][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WW domain-binding protein 4 (WBP4).